Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting to read:%0A%0A {0} %0A%0A {1}

LCN Capital Partners Selects Cushman & Wakefield to Explore Alternatives for 9900 Bren Road in Minnetonka, Minnesota

Bailey Webb • 3/28/2023
Cushman & Wakefield Engaged to Explore Alternatives Including Corporate Campus and Redevelopment for High-Profile Suburban Site 

MINNEAPOLIS, March 28, 2023 – LCN Capital Partners has engaged a Cushman & Wakefield team led by Executive Director Tom O’Brien and Executive Managing Director Dan Gleason to market 9900 Bren Road in Minnetonka, Minnesota, and seek strategic alternatives for the property, which has served as UnitedHealth Group’s corporate headquarters since 1998. 

The development at Bren Road and U.S. Highway 169 currently is a 20-acre corporate campus that includes a 10-story, 343,602-square-foot Class A office building. The property offers a combination of premier asset quality and outstanding location in Minneapolis’ most prominent suburban office submarket. New York-based LCN acquired the property from UnitedHealth Group in 2014 in a sale-leaseback transaction. The lease expires in December of 2024. 

Noted Cushman & Wakefield’s O’Brien, “9900 Bren is a distinctively well-positioned and unique corporate campus in the Twin Cities. With occupiers’ recent flight to quality, it has all the attributes today’s office users seek – attractive location, access to public transit, ample parking, and nearby walkways and green space. What’s more, the fully featured office tower has been meticulously maintained, and has all the features and amenities to support today’s hybrid workplace. 9900 provides a rare opportunity to present a turnkey campus environment that’s truly plug-and-play for another corporate user.”  

Given the boom in redevelopment and residential activity in the area, Cushman & Wakefield expects see interest from developers considering other uses for the property. 

According to Gleason, “The premium location, access and high-quality structure provide a strong base for redevelopment that could be converted to uses such as mixed-use luxury residential and retail, senior housing, hospitality and even education or government use – or a number of combinations. Working with the LCN team, we have a great opportunity to determine the best, long-term option for this property and the surrounding community.”  

Gleason added, “This is one of the best located properties in the entire Twin Cities - essentially at the crossroads of Edina, Minnetonka, Bloomington and Eden Prairie.  It provides easy access to Crosstown, Highway 169 and Interstate 494 as well as a nearby light rail station and the new Green Line which will connect the southwest suburbs and Downtown Minneapolis.”  

According to the City of Minnetonka’s 2040 Land Use Plan, the future zoning on this site, located within Opus Business Park, is mixed-use. For its part, the 640-acre Opus Business Park includes more than 2,400 existing or planned residential units, over 4.2 million square feet of commercial space and six miles of trails, As well as serving as UnitedHealth Group’s headquarters, the park’s tenants include Boston Scientific, American Family Insurance, The Opus Group and Opportunity Partners among the 136 business that call it home.  
About Cushman & Wakefield
Cushman & Wakefield (NYSE: CWK) is a leading global commercial real estate services firm for property owners and occupiers with approximately 52,000 employees in nearly 400 offices and 60 countries. In 2023, the firm reported revenue of $9.5 billion across its core services of property, facilities and project management, leasing, capital markets, and valuation and other services. It also receives numerous industry and business accolades for its award-winning culture and commitment to Diversity, Equity and Inclusion (DEI), sustainability and more. For additional information, visit

Interested in learning more?

Get in touch and we can assist with any additional information you need.

With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

You can change your preferences at any time by returning to this site or clicking on  Cookies

More Options
Agree and Close
These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
Agree All
Reject All